Wegener's granulomatosis: epidemiological and clinical features in a South Australian study
Date
2008
Authors
Hissaria, P.
Cai, F.
Ahern, M.
Smith, M.
Gillis, D.
Roberts-Thomson, P.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Internal Medicine Journal, 2008; 38(10):776-780
Statement of Responsibility
P. Hissaria, F. Z. J. Cai, M. Ahern, M. Smith, D. Gillis and P. Roberts-Thomson
Conference Name
Abstract
Background: The epidemiology of Wegener’s granulomatosis (WG)has shown a latitude-dependent predisposition in Northern Hemisphere and in New Zealand. There are no studies describing epidemiology or long-term follow up ofWG reported from Australia. The aims of this study were to describe the epidemiological and clinical features of WG in South Australia (SA). Methods: The 5-year incidence of WG in SA over the period 2001–2005 was determined using the International Classification of Diseases classification (M313) of the discharge diagnosis using the Integrated South Australian Activity Collection. A retrospective case record analysis of 30 patients fulfilling the American College of Rheumatology criteria forWGand managed at two regional hospitals over a 20-year period (1985–2004) was carried out. Results: The 5-year incidence of WG in SA was 56 per 106 (95% confidence interval 44.1–68.4 per 106). Therewereno regional or seasonal variations indisease occurrence. The demographic, clinical and serological features in the clinical study were similar to previously published studies. Significant treatment-related morbidity was noted with 50% of patients having atherosclerotic vascular complications. The median survival was 12 years. There were two important periods with greater risk of dying – in the first 5 years and after 10 years. Conclusion: The 5-year incidence of WG in SA is higher than that in the same latitudinal region in New Zealand (;34S). Atherosclerotic vascular disease was amajorlong-termmorbidity.Thereisincreasedincidenceofearlymortality,warranting theneedfor earlierdiagnosisandbetter therapies.Further studies fromSouthern Hemisphere are required for better epidemiological description of this disease.